{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:21Z","timestamp":1786987041869,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C19942\/A28832"],"award-info":[{"award-number":["C19942\/A28832"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RRNPSF-Jan 21\\u2216100003"],"award-info":[{"award-number":["RRNPSF-Jan 21\\u2216100003"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011703","name":"Yorkshire Cancer Research","doi-asserted-by":"publisher","award":["L389AA"],"award-info":[{"award-number":["L389AA"]}],"id":[{"id":"10.13039\/100011703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011703","name":"Yorkshire Cancer Research","doi-asserted-by":"publisher","award":["L389LM"],"award-info":[{"award-number":["L389LM"]}],"id":[{"id":"10.13039\/100011703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011703","name":"Yorkshire Cancer Research","doi-asserted-by":"publisher","award":["125713"],"award-info":[{"award-number":["125713"]}],"id":[{"id":"10.13039\/100011703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clon.2025.103861","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T08:05:02Z","timestamp":1746777902000},"page":"103861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dose Accumulation for Pelvic Stereotactic Ablative Radiotherapy Reirradiation"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7176-904X","authenticated-orcid":false,"given":"F.","family":"Slevin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2221-6358","authenticated-orcid":false,"given":"C.","family":"O'Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8675-3809","authenticated-orcid":false,"given":"J.","family":"Entwisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0060-0316","authenticated-orcid":false,"given":"J.","family":"Lilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-7344","authenticated-orcid":false,"given":"M.","family":"Nix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8491-1298","authenticated-orcid":false,"given":"M.","family":"Tyyger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2792-9218","authenticated-orcid":false,"given":"A.L.","family":"Appelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clon.2025.103861_bib1","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clon.2025.103861_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eururo.2019.10.008","article-title":"Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials","volume":"77","author":"Kishan","year":"2020","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.clon.2025.103861_bib3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.clon.2025.103861_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clon.2025.103861_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2025.103861_bib6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.clon.2025.103861_bib7","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2025.103861_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109947","article-title":"Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E(2)-RADIatE platform","volume":"189","author":"Willmann","year":"2023","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2025.103861_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2017.09.030","article-title":"Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review","volume":"125","author":"Murray","year":"2017","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2025.103861_bib10","first-page":"152","article-title":"Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles","volume":"3","author":"Nieder","year":"2013","journal-title":"Am J Cancer Res"},{"issue":"3","key":"10.1016\/j.clon.2025.103861_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/srao.2000.6593","article-title":"Tissue tolerance to reirradiation","volume":"10","author":"Nieder","year":"2000","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103861_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2025.103861_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109545","article-title":"Treatment plan optimisation for reirradiation","volume":"182","author":"Murray","year":"2023","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103861_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/0284186X.2021.1982145","article-title":"Dose summation and image registration strategies for radiobiologically and anatomically corrected dose accumulation in pelvic re-irradiation","volume":"61","author":"Nix","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clon.2025.103861_bib15","series-title":"Evidence review: efficacy, toxicity and cost-effectiveness of stereotactic ablative radiotherapy (SABR) in patients with metachronous extracranial oligometastatic cancer","year":"2019"},{"key":"10.1016\/j.clon.2025.103861_bib16","series-title":"Clinical Commissioning Policy: stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)","year":"2021"},{"key":"10.1016\/j.clon.2025.103861_bib17","series-title":"Basic clinical radiobiology","author":"Joiner","year":"2018"},{"issue":"3 Suppl","key":"10.1016\/j.clon.2025.103861_bib18","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","article-title":"Radiation dose-volume effects in the spinal cord","volume":"76","author":"Kirkpatrick","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"10.1016\/j.clon.2025.103861_bib19","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2025.103861_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"issue":"3 Suppl","key":"10.1016\/j.clon.2025.103861_bib21","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.ijrobp.2009.02.090","article-title":"Radiation dose-volume effects of the urinary bladder","volume":"76","author":"Viswanathan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"10.1016\/j.clon.2025.103861_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153831","article-title":"Brain Re-Irradiation Robustly Accounting for Previously Delivered Dose","volume":"15","author":"Thompson","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.clon.2025.103861_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7785\/tcrt.2012.500261","article-title":"Re-irradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region","volume":"11","author":"Abusaris","year":"2012","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.clon.2025.103861_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2011.03.010","article-title":"Second re-irradiation: efficacy, dose and toxicity in patients who received three courses of radiotherapy with overlapping fields","volume":"99","author":"Abusaris","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2025.103861_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejmp.2021.11.005","article-title":"Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience","volume":"92","author":"Augugliaro","year":"2021","journal-title":"Phys Med"},{"issue":"4","key":"10.1016\/j.clon.2025.103861_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.adro.2018.06.001","article-title":"Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability models","volume":"3","author":"Dipasquale","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clon.2025.103861_bib27","article-title":"Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy","volume":"39","author":"Li","year":"2023","journal-title":"Clin Translational Radiat Oncol"},{"issue":"6","key":"10.1016\/j.clon.2025.103861_bib28","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.adro.2020.07.017","article-title":"Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and Toxicity","volume":"5","author":"Smith","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"12","key":"10.1016\/j.clon.2025.103861_bib29","article-title":"The Dosimetric Analysis of Duodenal and Intestinal Toxicity After a Curative Dose Re-irradiation Using the Intensity-Modulated Radiotherapy for Abdominopelvic Lymph Node Lesions","volume":"15","author":"Yoshida","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.clon.2025.103861_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1021058","article-title":"Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration","volume":"12","author":"Cao","year":"2023","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.clon.2025.103861_bib31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","article-title":"UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy","volume":"34","author":"Diez","year":"2022","journal-title":"Clin Oncol (R Coll Radiol"},{"issue":"6","key":"10.1016\/j.clon.2025.103861_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/acm2.12481","article-title":"Re-irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectives","volume":"19","author":"McVicar","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.clon.2025.103861_bib35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2021.09.010","article-title":"An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation","volume":"164","author":"Slevin","year":"2021","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.clon.2025.103861_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.adro.2019.05.007","article-title":"The Special Medical Physics Consult Process for Reirradiation Patients","volume":"4","author":"Paradis","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"8","key":"10.1016\/j.clon.2025.103861_bib37","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.clon.2025.103861_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2013.02.002","article-title":"Aortic dose constraints when reirradiating thoracic tumors","volume":"106","author":"Evans","year":"2013","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103861_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clon.2022.09.047","article-title":"Launch of the UK SABR Consortium Pelvic Stereotactic Ablative Radiotherapy Re-irradiation Guidelines and National Audit","volume":"35","author":"Muirhead","year":"2023","journal-title":"Clin Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525001165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525001165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:35:54Z","timestamp":1762331754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655525001165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"alternative-id":["S0936655525001165"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2025.103861","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose Accumulation for Pelvic Stereotactic Ablative Radiotherapy Reirradiation","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2025.103861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"103861"}}